Rocksolid Light

Welcome to novaBBS (click a section below)

mail  files  register  newsreader  groups  login

Message-ID:  

Research is what I'm doing when I don't know what I'm doing. -- Wernher von Braun


tech / sci.electronics.design / Re: 12 month mitigation vs suppression strategy Covid19

Re: 12 month mitigation vs suppression strategy Covid19

<mdll0hpcdtv8ks0ioi9ef1godib02obt6d@4ax.com>

  copy mid

https://www.novabbs.com/tech/article-flat.php?id=90117&group=sci.electronics.design#90117

  copy link   Newsgroups: sci.electronics.design
Path: i2pn2.org!i2pn.org!eternal-september.org!reader02.eternal-september.org!.POSTED!not-for-mail
From: leg...@nospam.magma.ca (legg)
Newsgroups: sci.electronics.design
Subject: Re: 12 month mitigation vs suppression strategy Covid19
Date: Mon, 14 Feb 2022 17:21:17 -0500
Organization: A noiseless patient Spider
Lines: 287
Message-ID: <mdll0hpcdtv8ks0ioi9ef1godib02obt6d@4ax.com>
References: <ppqibgdqa2kcs6dr4fd064st0rlu6gd9nb@4ax.com> <0b86eg1s60nru5m1i8no5qmv674km2ipl1@4ax.com> <j6gggglco2l0o8vocov4gvai653136lu27@4ax.com> <kh2qig9tl6afa4j9cp32iffsaelvln25k4@4ax.com> <gc9cjg5jlsqu57gc18cj2feq87ujbrpged@4ax.com> <4i0plgps4aqj115kj5l7mvf7hfh678a8at@4ax.com> <pr51oghhnscrbfvp6o92l8orpcsdm1enc9@4ax.com> <4qkhqgp8jme81ss002hi3fg35j5s06oe0a@4ax.com> <kht6tgp3ool8jr80j05m55oeq447e7im7r@4ax.com> <6gbgvgh4fgt4mcgiapspru2q4hm9uj1orj@4ax.com>
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
Injection-Info: reader02.eternal-september.org; posting-host="86b9ed7c5f18e898bf53adb9a507073e";
logging-data="7083"; mail-complaints-to="abuse@eternal-september.org"; posting-account="U2FsdGVkX1/oX9E6GuAV6C1gsMkhp/TP"
Cancel-Lock: sha1:lzeZIlYRBiLjp9KyDJho8F97Ijk=
X-Newsreader: Forte Agent 4.2/32.1118
 by: legg - Mon, 14 Feb 2022 22:21 UTC

> Per capita comparisons are interesting, as they represent
> efforts, within political boundaries, equally.
> Data is easily obtained by visiting the data explorer page
> at Our World in Data:

> http://tiny.cc/ul41tz

>
> A 100ppm daily detection rate would, in one year, result in
> an approximately 4% penetration within a population.
>
> Testing of blood donor samples in Quebec suggests that covid-19
> antibodies are present in the local population at 3x positive
> virus detection test rate, in eaerly 2020.

> Testing for antibodies in India in May/Jun 2021, indicated that
> Covid 19 exposure was present in 67% of test subjects. This
> compared to a 7% figure recorded in the fall of 2020. A daily
> infection rate in excess of 2000ppm is suggested by this change.

> http://tiny.cc/cn8muz

>
> multiply ppm by population (in millions) for real numbers.
> China - 1397 million
> Iceland - 0.36 million
> US - 330 million
> Canada - 37 million
> Italy - 60 million
> Sweden - 10 million
> UK - 66 million
> Brazil - 210 million
> Peru - 32 million
> Chile - 19 million
> Argentina - 45 million
> Mexico - 127 million
> South Africa - 58 million
> Czech Republic - 10.7 million
> Israel - 10 million
> India - 1391 million
>
> Median age in Germany and Italy is 45-46yrs.
> Median age in Canada, UK and Sweden is 40-41yrs.
> Median age in US, China and Russia is 38.7, 38.4 and 37.6yrs respectively.
> Median age in Chile and Brazil is 33.7 and 31.3yrs respectively.
> Median age in Israel is 30.4yrs.
> Median age in Peru and Mexico is 27.5yrs.
> Median age in India is 26.8yrs.
> Median age in South Africa is 25yrs.
>

> Comparison charts, as of Jan 31 are available:

> http://ve3ute.ca/query/220131_cases_ppm_report_group.jpg
> http://ve3ute.ca/query/220131_cases_daily_ppm_report_group.jpg

> http://ve3ute.ca/query/220131_deaths_report_group.jpg
> http://ve3ute.ca/query/220131_deaths_ppm_report_group.jpg
> http://ve3ute.ca/query/220131_deaths_daily_ppm_report_group.jpg
> http://ve3ute.ca/query/211130_deaths_daily_greater_than_5ppm.jpg

> http://ve3ute.ca/query/220131_vaccine_doses_report_group.jpg
> http://ve3ute.ca/query/220131_vaccine_doses_daily_report_group.jpg
> http://ve3ute.ca/query/220131_vaccinations_completed_report_group.jpg

> Flu Season? Fatality comparison to past events in the U.S.A.
> Updated Jan 31 to include a second year trend or 'season'.

> http://ve3ute.ca/query/flu_season_029c.jpg

> Looks like everyone's going to get it, eventually, vaccinated
> or not - just reduced mortality amongst the vaccinated.

> A possible peaking in covid-omicron detections may be indicated.

> Past sero-immunity studies suggest that a 30% detection record
> could indicate widespread (>80%) penetration in a population.

As of Feb14:
US detections are at 233513ppm.(23.4%)
Detection rate is 522ppm/day and falling.
Fatalities are 2763ppm at 7.0ppm/day.
FR is 1.2% from a 229824ppm detection recorded 7 days previously.
Case FR short term is currently 0.6%.
US test rate is unreported (~4000ppm/day)
~20% of current tests are positive.
Vaccinations at 165% at 900ppm/day
- with 64% fully vaccinated.

Canada detections at 83810ppm (8.4%) ~ 363 days behind the US.
Detection rate at 251ppm/day and falling.
Fatalities are 932ppm at 2.8ppm/day. ~ 425 days behind the US.
FR is 1.1% from a 82052ppm detection recorded 7 days previously.
Case FR short term is currently 0.7%.
Canada test rate is 1610ppm/day
15.6% of current tests are positive.
Vaccinations at 210% at 3400ppm/day
- with 80% fully vaccinated.

Italy detections at 200533ppm. (20.1%)
Detection rate is 1145ppm/day and falling.
Fatalities are 2502ppm at 5.3ppm/day.
FR is 1.3% from a 192517ppm detection recorded 7 days previously.
Case FR short term is currently 0.3%.
Italy test rate is 10700ppm/day.
10.7% of current tests are positive.
Vaccinations at 219% at 3800ppm/day.
- with 78% fully vaccinated.

Sweden detections at 235954ppm (23.6%)
Detection rate is 1540ppm/day and falling.
Fatalities are 1624ppm at 4.5ppm/day.
FR is 0.7% from a 225172ppm detection recorded 7 days previously.
Case FR short term is currently 0.1%.
Sweden test rate is unreported (~4900ppm/day).
~30% of tests are positive.
Vaccinations at 197% at 4900ppm/day
- with 74% fully vaccinated.

UK detections at 269080ppm. (26.9%)
Detection rate is 1060ppm/day and possibly leveling below 1100ppm/day.
Fatalities are 2342ppm at 2.6ppm/day.
FR is 0.9% from a 261660ppm detection recorded 7 days previously.
Case FR short term is currently 0.3%.
UK test rate is 16160ppm/day.
6.6% of current tests are positive.
Vaccinations at 204% at 800ppm/day
- with 71% fully vaccinated.

Brazil detections at 128475ppm. (12.8%)
Detection rate is 632ppm/day and falling.
Fatalities are 2985ppm at 4.1ppm/day
FR is 2.4% from a 124052ppm detection recorded 7 days previously.
Case FR short term is currently 0.5% .
Brazil test rate is 320ppm/day.
No test positivity rate is practical.
Vaccinations at 177% at 5700ppm/day
- with 71% fully vaccinated.

Peru detections at 103290ppm. (10.3%)
Detection rate is 352ppm/day and falling.
Fatalities are 6247ppm at 6.0ppm/day.
FR is 6.2% from a 100826ppm detection recorded 7 days previously.
Case FR short term is currently 0.5% .
Peru test rate is 2530ppm/day.
13.9% of tests are positive - the first practical test rate reported.
Vaccinations at 171% at 2400ppm/day
- with 69% fully vaccinated

Chile detections at 136455ppm (13.6%)
Detection rate is 1856ppm/day and rising.
Fatalities are 2111ppm at 4.3ppm/day.
FR is 1.9% from a 111269ppm detection recorded 14 days previously.
Case FR short term is currently 0.3% .
Chile test rate is 6260ppm/day.
29.6% of current tests are positive.
Vaccinations at 247% at 3000ppm/day
- with 89% fully vaccinated.

Argentina detections at 191523ppm (19.2%)
Detection rate is 453ppm/day and falling.
Fatalities are 2721ppm at 4.4ppm/day.
FR is 1.4% from a 188350ppm detection recorded 7 days previously.
Case FR short term is currently 0.4% .
Argentina test rate is 830ppm/day.
No test positivity rate is practical.
Vaccinations at 199% at 5700ppm/day
- with 78% fully vaccinated.

Mexico detections at 40563ppm (4.1%)
Detection rate is 156ppm/day and falling.
Fatalities are 2401ppm at 3.6ppm/day.
FR is 6.1% from a 39547ppm detection recorded 7 days previously.
Case FR short term is currently 1.3% .
Mexico test rate is 130ppm/day.
No test positivity rate is practical.
Vaccinations at 132% at 3100ppm/day.
- with 60% fully vaccinated.

South Africa detections at 60654ppm (6.1%)
Detection rate is 42ppm/day and falling.
Fatalities are 1615ppm at 2.8ppm/day.
FR is 2.7% from a 60357ppm detection recorded 7 days previously.
Case FR short term is currently 5.2% .
SA test rate is 510ppm/day.
8.2% of current tests are positive.
Vaccinations at 52% at 2000ppm/day
- with 29% fully vaccinated.(a rounding error?)

Czech detections at 316680ppm (31.7%)
Detection rate is 2154ppm/day and falling.
Fatalities are 3526ppm at 4.9ppm/day.
FR is 1.2% from a 301604ppm detection recorded 7 days previously.
Case FR short term is currently 0.1% .
Czech test rate is 9110ppm/day.
23.6% of current tests are positive.
Vaccinations at 161% at 1200ppm/day
- with 64% fully vaccinated.

India detections at 30620ppm (3.1%)
Detection rate is 40ppm/day and falling.
Fatalities at 365ppm at 0.6ppm/day.
FR is 1.2% from a 30337ppm detection recorded 7 days previously.
Case FR short term is currently 0.5% .
India test rate 1080ppm/day.
3.7% of current tests are positive.
Vaccinations at 124% at 3300ppm/day
- with 54% fully vaccinated.

Israel detections at 368754ppm (36.9%)
Detection rate is 3530ppm/day and falling.
Fatalities at 1027ppm at 5.6ppm/day.
FR is 0.3% from a 344047ppm detection recorded 7 days previously.
Case FR short term is currently 0.1% .
Israel test rate is 14640ppm/day.
24.1% of current tests are positive
Vaccinations at 193% at 600ppm/day.
- with 66% fully vaccinated.

Fatality rate hotspots (>5ppm/day) :

Bosnia - 13.7ppm/day
Bulgaria - 13.1ppm/day
Georgia - 12.4ppm/day
Croatia - 11.8ppm/day
Macedonia - 11.6ppm/day
Hungary - 9.2ppm/day
Greece - 9.1ppm/day
Serbia - 9.1ppm/day
Slovenia - 7.3ppm/day
USA - 7.0ppm/day
Lithuania - 6.8ppm/day
Trinidad and Tobago - 6.7ppm/day
Peru - 6.0ppm/day
Paraguay - 5.9ppm/day
Poland - 5.8ppm/day
Estonia - 5.8ppm/day
Latvia - 5.6ppm/day
Israel - 5.6ppm/day
Spain - 5.4ppm/day
Italy - 5.3ppm/day
Tunisia - 5.3ppm/day
Ukraine - 5.3ppm/day

> Doses applied in Israel, Chile and other highly vaccinated countries
> appear to be providing 3rd dose booster reinforcement, without
> contributing to completed vaccinations.

> Full vaccination levels are apparently stalled around 60% in the US
> and other regions with signifigant reactionary movements.

> The increased transmissibility of omicron variants have contributed
> to the rise in detections, world-wide, after Nov 2021. So far, no
> increase in mortality is associated with this variant.

> Chile participated in Phase 3 trials for AstraZeneca,
> Johnson & Johnson, Sinovac and CanSino. Chile has contracts
> with AstraZeneca, Johnson & Johnson, Pfizer and Sinovac.
> Sinovac is their regular supplier of seasonal flu vaccine.
> Sinovac's 'CoronaVac' vaccine does not require sub-zero storage
> temperatures. About 60% of Chile's contracted 80 million doses
> are from Sinovac.
>
> Chile maintains a Public Health service database that includes
> regular vaccination scheduling. Using these resources alone
> allowed vaccination rates as high as 1 million doses per week
> to be delivered as early as mid-February. Approval of vaccine
> use was based on published Phase 1 and Phase 2 reporting.
>

> Reducing detections and fatalities in unvaccinated India/Nepal
> seem to indicate reducing virulence for the delta variant.
> Detection rates in S.Africa had also turned around until the
> recent influences of the omicron variant. So far there is no
> corresponding increase in fatalities.

RL

SubjectRepliesAuthor
o 12 month mitigation vs suppression strategy Covid19

By: legg on Mon, 3 May 2021

130legg
server_pubkey.txt

rocksolid light 0.9.81
clearnet tor